MEDNATION AG (EIF.DE) Stock Fundamental Analysis
Europe - FRA:EIF - DE0005653604 - Common Stock
3.04 EUR
-0.02 (-0.65%)
Taking everything into account, EIF scores 3 out of 10 in our fundamental rating. EIF was compared to 31 industry peers in the Health Care Providers & Services industry. EIF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EIF is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
EIF had positive earnings in the past year.
EIF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EIF reported negative net income in multiple years.
Each year in the past 5 years EIF had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.58%, EIF is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
EIF has a Return On Equity of 4.66%. This is comparable to the rest of the industry: EIF outperforms 41.94% of its industry peers.
EIF has a worse Return On Invested Capital (1.64%) than 80.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EIF is below the industry average of 6.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.58% | ||
| ROE | 4.66% | ||
| ROIC | 1.64% |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
1.3 Margins
EIF has a Profit Margin of 1.13%. This is in the lower half of the industry: EIF underperforms 61.29% of its industry peers.
With a Operating Margin value of 2.34%, EIF is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of EIF has declined.
EIF has a Gross Margin of 91.35%. This is amongst the best in the industry. EIF outperforms 90.32% of its industry peers.
In the last couple of years the Gross Margin of EIF has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.34% | ||
| PM (TTM) | 1.13% | ||
| GM | 91.35% |
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
2. Health
2.1 Basic Checks
EIF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EIF has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EIF has less shares outstanding
The debt/assets ratio for EIF has been reduced compared to a year ago.
2.2 Solvency
EIF has an Altman-Z score of 1.94. This is not the best score and indicates that EIF is in the grey zone with still only limited risk for bankruptcy at the moment.
EIF has a Altman-Z score of 1.94. This is comparable to the rest of the industry: EIF outperforms 54.84% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that EIF is somewhat dependend on debt financing.
EIF has a Debt to Equity ratio (0.98) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.98 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.94 |
ROIC/WACC0.38
WACC4.27%
2.3 Liquidity
EIF has a Current Ratio of 1.73. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EIF (1.73) is better than 77.42% of its industry peers.
EIF has a Quick Ratio of 1.50. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
EIF has a Quick ratio of 1.50. This is amongst the best in the industry. EIF outperforms 87.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.51%.
EIF shows a small growth in Revenue. In the last year, the Revenue has grown by 4.11%.
EIF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.13% yearly.
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.00, EIF is valued correctly.
Based on the Price/Earnings ratio, EIF is valued a bit cheaper than the industry average as 61.29% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.89. EIF is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | N/A |
4.2 Price Multiples
EIF's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.06 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for EIF!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EIF (11/14/2025, 7:00:00 PM)
3.04
-0.02 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap9.48M
Revenue(TTM)50.89M
Net Income(TTM)575.90K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | N/A | ||
| P/S | 0.19 | ||
| P/FCF | N/A | ||
| P/OCF | 24.76 | ||
| P/B | 0.77 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 10.06 |
EPS(TTM)0.19
EY6.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.12
OCFY4.04%
SpS16.31
BVpS3.96
TBVpS3.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.58% | ||
| ROE | 4.66% | ||
| ROCE | 3.86% | ||
| ROIC | 1.64% | ||
| ROICexc | 1.8% | ||
| ROICexgc | 1.8% | ||
| OM | 2.34% | ||
| PM (TTM) | 1.13% | ||
| GM | 91.35% | ||
| FCFM | N/A |
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score5
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.98 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.43 | ||
| Cap/Depr | 60.09% | ||
| Cap/Sales | 0.81% | ||
| Interest Coverage | 3.91 | ||
| Cash Conversion | 20.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 1.94 |
F-Score5
WACC4.27%
ROIC/WACC0.38
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.69%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.02%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y-40.8%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%
MEDNATION AG / EIF.DE FAQ
Can you provide the ChartMill fundamental rating for MEDNATION AG?
ChartMill assigns a fundamental rating of 3 / 10 to EIF.DE.
What is the valuation status of MEDNATION AG (EIF.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to MEDNATION AG (EIF.DE). This can be considered as Overvalued.
Can you provide the profitability details for MEDNATION AG?
MEDNATION AG (EIF.DE) has a profitability rating of 3 / 10.
What is the financial health of MEDNATION AG (EIF.DE) stock?
The financial health rating of MEDNATION AG (EIF.DE) is 5 / 10.